SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is experiencing a significant surge following its latest earnings, with bulls championing the success of 'Opendoor 2.0' as evidenced by improved unit economics, faster inventory turns, and a projected path to Q2 EBITDA profitability, despite ongoing bear sentiment focused on the reported GAAP losses and revenue decline.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as weaker-than-expected GDP and hotter inflation ignite community debates on rate cuts versus stagflation. Additionally, escalating geopolitical tensions and an awaited Supreme Court ruling on tariffs are contributing to market uncertainty and active discussion among traders.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL's stock is experiencing a dramatic decline after its NHS-Galleri trial missed its primary endpoint for reducing late-stage cancer diagnoses, igniting a fervent community debate where bears foresee further collapse while bulls claim the selloff is an overreaction, pointing to strong secondary data and a robust cash position.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Kennedy Space Center, FL.

Starfighters Space Inc

Starfighters Space (FJET) is generating significant buzz ahead of its NYSE opening bell ceremony and news regarding its STARLAUNCH platform's progress with GE Aerospace, placing it in the context of growing defense and aerospace AI spending. Community discussion is polarized, with many anticipating a substantial short squeeze while others express strong skepticism, labeling it a "pump and dump" given concerns over revenue and recent news details.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as strong IBSRELA growth and a patent extension to 2042 are overshadowed by a Q4 EPS miss and increased 2026 operating expenses, sparking community debate about near-term profitability and ongoing speculation about a potential acquisition.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending amid market discussions around disappointing economic data, looming Supreme Court tariff decisions, and escalating geopolitical tensions. The community is actively debating the market's surprising resilience, with many observing that negative catalysts are not leading to significant downside.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is at the center of investor conversation due to an impending Supreme Court decision on tariffs and intensified scrutiny surrounding the Epstein files following a notable international arrest. The community is actively debating economic reports and navigating ongoing concerns about potential stock dilution and market manipulation.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending as a battleground stock caught in the broader software sector sell-off, with an intense community debate raging over whether AI will disrupt its core business or enhance its strong financial performance and deeply entrenched user base. Despite robust cash flow and aggressive share buybacks, the stock continues to face significant downward pressure from short interest and market skepticism.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending following the dual announcement of a $100 million public stock offering and a $100 million royalty funding agreement, sparking community discussion on whether the capital raise is strategic for future commercialization or represents significant dilution. While some investors express concern over immediate share dilution, others view the combined financing as a disciplined move to build runway and validate its pipeline ahead of crucial regulatory milestones, particularly the BLA submission for its lead prostate cancer candidate.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending with intense community anticipation surrounding a key regulatory decision for Bysanti in CNS disorders, coupled with growing excitement for its Nereus asset's substantial potential in GLP-1 induced nausea. Investors are actively debating the company's deeply undervalued status and the high likelihood of a significant re-rating or major pharmaceutical buyout, driven by these pivotal pipeline developments and a tight public float.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pacific Biosciences of California (NASDAQ:PACB) Insider Sells $89,824.41 in Stock

Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) insider Oene Mark Van sold 55,107 shares of the firm's stock in a transaction dated Wednesday, February 18th. The shares were...

Pacific Biosciences of California (NASDAQ:PACB) Insider Michele Farmer Sells 14,952 Shares

Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) insider Michele Farmer sold 14,952 shares of the firm's stock in a transaction that occurred on Wednesday, February 18th. The...

Pacific Biosciences of California (NASDAQ:PACB) Insider Sells $55,639.70 in Stock

Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) insider Michele Farmer sold 35,215 shares of the business's stock in a transaction on Tuesday, February 17th. The stock was...

Oene Mark Van Sells 129,790 Shares of Pacific Biosciences of California (NASDAQ:PACB) Stock

Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) insider Oene Mark Van sold 129,790 shares of the business's stock in a transaction on Tuesday, February 17th. The shares were...

Pacific Biosciences of California (NASDAQ:PACB) Insider Sells $229,624.62 in Stock

Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) insider Christian Henry sold 140,874 shares of Pacific Biosciences of California stock in a transaction dated Wednesday...

Pacific Biosciences of California (NASDAQ:PACB) Insider Christian Henry Sells 331,793 Shares

Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) insider Christian Henry sold 331,793 shares of the business's stock in a transaction that occurred on Tuesday, February 17th...

Pacific Biosciences of California (NASDAQ:PACB) Stock Price Down 6.8% - What's Next?

Pacific Biosciences of California (NASDAQ:PACB) Stock Price Down 6.8% - Time to Sell...

PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up

PACB beats Q4 estimates as revenue jumps 14%, gross margin hits 41% and 2026 revenues are projected in the range of $165-$180M after strategic moves.

Pacific Biosciences of California Q4 Earnings Call Highlights

Pacific Biosciences of California (NASDAQ:PACB) reported fourth-quarter and full-year 2025 results that management said exceeded expectations, driven by record consumables revenue and stronger...

Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of +36.84% and +9.42%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

PACB
Pacific Biosciences of California Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PACB News

PACBPacific Biosciences of California Inc